You are viewing: Europe Structural Heart Devices Market analysis

The Europe Structural Heart Devices Market was valued at $4800.1 Million in 2024 and projected to reach to $7398.8 Million by 2029, representing a compound annual growth rate of 9.0%. Europe's structural heart devices market is positioned for sustained expansion through 2029, driven by an aging population with increasing cardiovascular disease prevalence and growing adoption of catheter-based interventions.

Europe Structural Heart Devices Market (2024-2029) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

Europe Structural Heart Devices Market Trends and Insights

  • This 9.0% compound annual growth rate reflects Europe's aging population, increasing prevalence of structural heart conditions, and rising adoption of minimally invasive interventional procedures across the region.
  • Europe maintains a mature healthcare infrastructure with strong regulatory frameworks and reimbursement pathways that support device innovation and patient access. The European market benefits from advanced healthcare systems, high diagnostic capabilities, and established clinical practice guidelines that drive demand for structural heart solutions.
  • Europe's emphasis on value-based care and cost-effective treatment alternatives has accelerated adoption of transcatheter and percutaneous devices.
  • Between 2024 and 2029, Europe is expected to see continued expansion driven by aging demographics, improved clinical evidence, and increasing physician expertise in structural heart interventions across major markets including Germany, France, Italy, Spain, and the United Kingdom..

Key Market Statistics

  • CAGR (2024-2029) 9.0% CAGR
  • Market Size, 2024 ~USD 4800.1 Million
  • Forecast, 2029 ~USD 7398.8 Million
  • Geography Europe

Europe Structural Heart Devices Market Overview

Aging Population Driving Demand :

Europe's rapidly aging demographic is significantly increasing the prevalence of structural heart conditions, creating sustained demand for innovative device solutions across the region's healthcare systems.

Minimally Invasive Procedure Adoption :

European healthcare providers are increasingly adopting minimally invasive interventional procedures, reducing patient recovery times and hospital stays while driving structural heart device utilization.

Strong Regulatory Framework :

Europe's mature regulatory environment and CE marking requirements ensure high-quality device standards, fostering trust among healthcare providers and patients in structural heart interventions.

Leading Market Contributors :

Germany, UK, Italy, and France represent the largest European markets, collectively accounting for the majority of regional structural heart device adoption and innovation.

Europe Structural Heart Devices Market Dynamics

  • Healthcare systems across the region are investing in advanced structural heart technologies, including transcatheter aortic valve replacement (TAVR) and left atrial appendage (LAA) closure devices.
  • Reimbursement improvements and clinical evidence supporting minimally invasive approaches continue to accelerate market penetration.
  • The region's mature healthcare infrastructure and strong regulatory standards support continued innovation and device adoption across major European markets..

Related Ecosystem

Medical Devices

Top Technologies
  • Polymerase Chain Reaction (PCR)
  • Magnetic Resonance Imaging (MRI)
  • Disposable Autoinjectors
  • Pulse Oximeters
  • Blood Pressure Monitors
Top Companies
  • Medtronic plc
  • Abbott Laboratories
  • Stryker Corporation
  • Becton, Dickinson and Company
  • CONMED Corporation

    Key Takeaways

    • Europe's structural heart devices market will grow from $4.8B in 2024 to $7.4B in 2029, representing a 9.0% CAGR driven by aging populations and increased disease prevalence across the region.
    • Europe's mature healthcare infrastructure, strong regulatory frameworks, and established reimbursement systems position the region as a leader in structural heart device adoption and innovation.
    • Minimally invasive transcatheter and percutaneous procedures are gaining traction throughout Europe due to clinical efficacy, reduced patient recovery times, and alignment with value-based care initiatives.
    • Major European markets including Germany, France, Italy, Spain, and the United Kingdom will drive regional growth through increased physician training, improved clinical evidence, and expanding patient access to structural heart interventions.

    Structural Heart Devices Market Report Scope

    Report Metric Details
    Base Year 2024
    Fastest Growing Segment TAVR/TAVI PROCEDURES (Type)
    Forecast Period 2024-2029
    Growth Rate CAGR of 9.5% from 2024 to 2029
    Largest Segment HOSPITALS (End User)
    Market Size Base Year (Billions) ~USD 16.32 (2024)
    Revenue Forecast (Billions) ~USD 25.69 (2029)
    Segments Covered Procedure, Type, Product, End User, Accessories

    Europe Structural Heart Devices Market Report Segmentation

    5 segment dimensions are covered across the global market.

    By Procedure

    • Repair Procedures
    • Replacement Procedures

    By Type

    • Annuloplasty
    • Biological Valves
    • Catheters
    • Closure Procedures
    • Guidewires
    • Mechanical Valves
    • Other Accessories
    • Savr Procedures
    • Sheaths
    • Surgical Heart Valves
    • Surgical Valves
    • Tavr/Tavi Procedures
    • Teer Procedures
    • Tmvr Procedures
    • Transcatheter Aortic Valve Replacement (Tavr)
    • Transcatheter Heart Valves
    • Transcatheter Mitral Valve Replacement (Tmvr)
    • Valvuloplasty

    By Product

    • Accessories
    • Annuloplasty Rings
    • Heart Valve Devices
    • Occluders, Closure Systems And Delivery Systems
    • Occluders, Closure Systems, And Delivery Systems

    By End User

    • Ambulatory Surgical Centers
    • Ambulatory Surgical Centres
    • Hospitals
    • Other Accessories
    • Other End Users
    • Other End Users (Cath Labs, Cardiac Centers )
    • Other End Users (Cath Labs, Cardiac Centers)
    • Other End Users (Cath Labs, Cardiac Centres)
    • Others End Users

    By Accessories

    • Catheters
    • Guidewires
    • Other Accessories
    • Sheaths

    EUROPE: STRUCTURAL HEART DEVICES MARKET, BY END USER, 2022–2029

    Segment20222023202420252026202720282029CAGR (%)
    AMBULATORY SURGICAL CENTERS452.7490.6530.1573.2619.9671.3727.6789.38.3
    HOSPITALS3161.43449.33751.34083.34445.64845.85287.15773.59
    OTHER ACCESSORIES429.1472.5518.7569.8626.1688.8758.583610
    TOTAL4043.14412.44800.15226.35691.662066773.37398.89

    REST OF EUROPE: STRUCTURAL HEART DEVICES MARKET, BY END USER,2022–2029

    Segment20222023202420252026202720282029CAGR (%)
    AMBULATORY SURGICAL CENTERS51.155.159.263.668.473.779.485.77.7
    HOSPITALS362.3393.1425.3460.4498.5540.4586.4636.88.4
    OTHER END USERS (CATH LABS, CARDIAC CENTERS)47.552.156.862.167.874.281.3899.4
    TOTAL460.9500.3541.3586.1634.8688.3747.1811.68.4

    Target Audience

    • Medical Device Manufacturers : Manufacturers need Europe-specific market data to optimize product portfolios, identify expansion opportunities, and develop region-tailored commercialization strategies for structural heart devices.
    • Healthcare Investors & PE Firms : Investors require detailed European market analysis to evaluate acquisition targets, assess growth potential, and make informed capital allocation decisions in the structural heart sector.
    • Hospital & Healthcare Systems : Healthcare administrators need market intelligence to justify capital investments in structural heart programs, benchmark adoption rates, and plan procurement strategies across European facilities.
    • Regulatory & Compliance Professionals : Regulatory specialists require Europe-specific insights on CE marking pathways, reimbursement requirements, and healthcare system variations to navigate market entry and compliance.
    • Market Research & Strategy Consultants : Consultants need comprehensive European market data to support client advisory work, competitive analysis, and strategic planning in the structural heart devices industry.

    Europe vs. other regions

    HowEurope compares to the other 3 regional blocs covered in this market.

    North America
    ~USD 9635.2 Million · 10% wtd CAGR ·
    Asia Pacific
    ~USD 6116.2 Million · 10.2% wtd CAGR ·
    Latin America
    ~USD 1659.2 Million · 7.8% wtd CAGR ·
    Middle East & Africa
    ~USD 883.2 Million · 7.7% wtd CAGR ·

    Countries within Europe - compare and drill down

    Country2025 size (native)
    GermanyUSD 1149.7 Million
    UKUSD 736.9 Million
    FranceUSD 559.8 Million
    ItalyUSD 699.9 Million
    SpainUSD 406.8 Million
    Rest Of EuropeUSD 433.3 Million

    Country market size visualization

    Germany
    USD 1149.7 Million
    UK
    USD 736.9 Million
    France
    USD 559.8 Million
    Italy
    USD 699.9 Million
    Spain
    USD 406.8 Million
    Rest Of Europe
    USD 433.3 Million

    Reasons to Buy this Report

    • Country-Level Market Insights : Detailed market sizing and growth projections for Germany, UK, Italy, France, Spain, and Rest of Europe, enabling targeted market entry and expansion strategies.
    • Demographic & Clinical Trends : Comprehensive analysis of Europe's aging population dynamics, disease prevalence patterns, and clinical adoption rates driving structural heart device demand across the region.
    • Competitive Landscape Analysis : Strategic intelligence on leading device manufacturers, market consolidation trends, and competitive positioning within Europe's mature structural heart devices sector.
    • Reimbursement & Regulatory Insights : In-depth understanding of European reimbursement policies, CE marking requirements, and healthcare system variations affecting device adoption and pricing strategies.
    • Growth Opportunity Identification : Clear identification of high-growth segments, emerging markets within Europe, and underserved patient populations to guide investment and commercialization decisions.

    Frequently asked questions

    What is the current size of Europe's structural heart devices market?

    Europe's structural heart devices market was valued at $4,800.1 million in 2024 and is projected to reach $7,398.8 million by 2029, growing at a 9.0% CAGR.

    What factors are driving growth in Europe's structural heart devices market?

    Europe's market growth is driven by an aging population, increasing prevalence of structural heart conditions, rising adoption of minimally invasive procedures, strong healthcare infrastructure, and established reimbursement pathways that support device innovation.

    Which European countries are leading the structural heart devices market?

    Major markets driving Europe's structural heart devices growth include Germany, France, Italy, Spain, and the United Kingdom, which benefit from advanced healthcare systems and high diagnostic capabilities.

    What types of structural heart devices are most commonly used in Europe?

    Europe shows strong adoption of transcatheter and percutaneous devices for conditions such as atrial septal defects, patent foramen ovale closure, and valve repair or replacement, reflecting the region's preference for minimally invasive interventions.

    How does Europe's structural heart devices market compare to global trends?

    Europe's 9.0% CAGR is slightly below the global 9.5% CAGR, reflecting the region's mature market status; however, Europe maintains higher adoption rates of advanced minimally invasive technologies and stronger regulatory oversight compared to emerging markets.

    RESEARCH METHODOLOGY

    The study involved four major activities to estimate the current size of the Structural heart devices market. Exhaustive secondary research was done to collect information on the market and its different subsegments. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. Thereafter, market breakdown and data triangulation procedures were used to estimate the market size of the segments and subsegments.

    Secondary Research

    In the secondary research process, various secondary sources such as annual reports, press releases & investor presentations of companies, white papers, certified publications, articles by recognized authors, gold-standard & silver-standard websites, regulatory bodies, and databases (such as D&B Hoovers, Bloomberg Business, and Factiva) were referred to to identify and collect information for the study of Structural heart devices market. It was also used to obtain important information about the top players, market classification, and segmentation according to industry trends to the bottom-most level, geographic markets, and key developments related to the market. A database of the key industry leaders was also prepared using secondary research.

    Primary Research

    Extensive primary research was conducted after obtaining information regarding the Structural heart devices market scenario through secondary research. Several primary interviews were conducted with market experts from both the demand and supply sides across major countries of North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. Primary data was collected through questionnaires, emails, and telephonic interviews. The primary sources from the supply side included various industry experts, such as Chief X Officers (CXOs), Vice Presidents (VPs), Directors from business development, marketing, product development/innovation teams, and related key executives from manufacturers; distributors operating in the Structural heart devices market.; and key opinion leaders.

    Primary interviews were conducted to gather insights such as market statistics, data on revenue collected from the products and services, market breakdowns, market size estimations, market forecasting, and data triangulation. Primary research also helped in understanding the various trends related to technology, application, vertical, and region. Stakeholders from the demand side customers/end users who are using infection control products were interviewed to understand the buyer’s perspective on the suppliers, products, and their current usage and the future outlook of their business, which will affect the overall market.

    The following is a breakdown of the primary respondents:

    Structural Heart Devices Market

    Note 1: C-level primaries include CEOs, COOs, CTOs, and VPs.

    Note 2: Other primaries include sales managers, marketing managers, and product managers.

    Note 3: Companies are classified into tiers based on their total revenue.

    As of 2023: Tier 1=>USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, Tier 3=< USD 500 million.

    To know about the assumptions considered for the study, download the pdf brochure

    Market Size Estimation

    The research methodology used to estimate the size of the Structural heart devices market includes the following details.

    The market sizing of the market was undertaken from the global side.

    Country-level Analysis: The size of the Structural heart devices market was obtained from the annual presentations of leading players and secondary data available in the public domain. The share of products in the overall Structural heart devices market was obtained from secondary data and validated by primary participants to arrive at the total Structural heart devices market. Primary participants further validated the numbers.

    Geographic market assessment (by region & country): The geographic assessment was done using the following approaches:

    Approach 1: Geographic revenue contributions/splits of leading players in the market (wherever available) and respective growth trends

    Approach 2: Geographic adoption trends for individual product segments by end users and growth prospects for each of the segments (assumptions and indicative estimates validated from primary interviews)

    At each point, the assumptions and approaches were validated through industry experts contacted during primary research. Considering the limitations of data available from secondary research, revenue estimates for individual companies (for the overall Structural heart devices market and geographic market assessment) were ascertained based on a detailed analysis of their respective product offerings, geographic reach/strength (direct or through distributors or suppliers), and the shares of the leading players in a particular region or country.

    Global Structural heart dsevices market size : Top-Down and Bottom-Up Approach

    Structural Heart Devices Market

    Data Triangulation

    The market was split into several segments and subsegments after arriving at the overall market size—using the market size estimation processes. Data triangulation and market breakdown procedures were employed to complete the overall market engineering process and arrive at the exact statistics of each market segment and sub-segment. The data was triangulated by studying various factors and trends from both the demand and supply sides in the Structural heart devices market.

    Market Definition

    Structural Heart devices are used to treat conditions such as aortic valve disease, mitral valve disease, atrial septal defect, ventricular septal defect, hypertrophic cardiomyopathy, and tricuspid and pulmonic valve disease. Structural heart devices can be used to close holes in the heart, open narrowed heart valves, or replace damaged valves.

    Stakeholders

    • Medical Device Manufacturers
    • Cardiologists
    • Interventional Cardiologist
    • Healthcare institutions (hospitals and outpatient clinics)
    • Distributors and suppliers
    • Research institutes
    • Health insurance payers
    • Market research and consulting firms

    Report Objectives

    • To define, describe, segment, and forecast the global Structural heart devices market by product, procedure, end user, and region.
    • To provide detailed information about the factors influencing market growth (such as drivers, restraints, opportunities, and challenges)
    • To analyze micromarkets1 concerning individual growth trends, prospects, and contributions to the overall Structural heart devices market.
    • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players.
    • To forecast the size of the Structural heart devices market in five main regions along with their respective key countries, namely, North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa
    • To profile key players in the global Structural heart devices market and comprehensively analyze their core competencies2 and market shares.
    • To track and analyze competitive developments such as acquisitions, expansions, partnerships, agreements, and collaborations; and product launches and approvals.
    • To benchmark players within the Structural heart devices market using the "Competitive Leadership Mapping" framework, which analyzes market players on various parameters within the broad categories of business and product strategy.

    Get the Full Structural Heart Devices Market Report

    Full forecast, segment splits, and company analysis for all Structural Heart Devices Market.

    Need a Tailored Report?

    Customize this report to your needs

    Get 10% FREE Customization

    Customize This Report
    Fact checked
    DMCA.com Protection Status